 Assessment cure schistosomiasis patients chemotherapy praziquantel quantitation anodic antigen CAA urine kinetics anodic antigen CAA levels urine Egyptian male patients Schistosoma mansoni mansoni haematobium treatment weeks chemotherapy quantitative enzyme-linked immunosorbent assay ELISA CAA serum urine samples patients possibility circadian variability urine CAA levels samples patients intervals period significant differences CAA titers Seventeen patients praziquantel weeks CAA titers serum urine week therapy Thereafter profile CAA titer urine parallel delayed decline serum serum CAA titers negative weeks treatment urine titers negative weeks weeks positive patients low titers significant quantitative correlation CAA titer serum urine treatment Seventeen Egyptian control active schistosome infection negative CAA serum urine results CAA urine assay sensitive non-invasive method disease assay efficacy schistosome chemotherapy